# Clinical Closure v1.4 — Read-Only Change Impact & Dependency Audit

## Status

**READ-ONLY AUDIT — BLOCKED BY UNDEFINED CHANGE SCOPE**

No Figma changes were made. No v1.3 frozen artifact was modified. No v1.4 implementation is authorized.

## 1. Audit scope

This audit evaluates the currently initialized v1.4 proposal against the frozen Clinical Closure v1.3 baseline and its documented cross-module boundaries.

The audit is intentionally read-only with respect to product/design implementation. It does not authorize Figma writes, component changes, architecture changes, field changes, backend behavior, or canonicalization.

## 2. Source baseline inspected

- `CHANGE_PROPOSAL_V1_4.md`
- `ARCHITECTURE_V1_3_PROPOSAL.md`
- `FIELD_SPECIFICATION_V1_3.md`
- `CROSS_MODULE_DEPENDENCY_AUDIT_V1_3.md`
- `CANONICALIZATION_FREEZE_AUTHORIZATION_V1_3.md`

## 3. Overall result

**BLOCKED — no concrete v1.4 change has been defined yet.**

The v1.4 proposal correctly states `PROPOSED — NOT APPROVED` and deliberately leaves the proposed change, problem, proposed behavior, affected areas, risks, and acceptance criteria as `PENDING DEFINITION`.

Because there is no concrete change request, an impact/dependency audit cannot truthfully determine which modules, fields, components, ownership boundaries, or interactions would change.

This is not a failure of the v1.3 architecture. It is a scope-definition gate.

## 4. Frozen v1.3 baseline protection

**PASS**

The v1.3 baseline remains explicitly protected:

- architecture — frozen;
- field specification — frozen;
- canonical Figma composition — frozen;
- Final QA — passed;
- canonicalization — complete.

The v1.4 proposal explicitly states that v1.3 remains frozen while the proposal is evaluated.

## 5. Architecture impact

**UNDETERMINABLE — concrete change required**

No architecture delta can be approved or rejected until the proposed problem and intended behavior are specified.

Potential questions for the next audit iteration:

- Does v1.4 require a new field?
- Does it alter an existing field's ownership or semantics?
- Does it require a new conditional state?
- Does it require a new top-level region?
- Does it alter Save/Cancel semantics?
- Does it alter the Shared Visit lifecycle boundary?

No answer is inferred at this stage.

## 6. Field specification impact

**UNDETERMINABLE — concrete change required**

No new or changed field has been proposed.

No field may be invented merely to populate v1.4.

## 7. Design-system impact

**UNDETERMINABLE — concrete change required**

No component, variant, vocabulary, or interaction change has been proposed.

The v1.3 design-system invariants remain in force until a specific v1.4 requirement demonstrates otherwise.

## 8. Cross-module dependency impact

**UNDETERMINABLE — concrete change required**

The existing v1.3 boundaries remain the default constraints:

### Shared Visit

Remains sole owner of Visit State and lifecycle transition unless a future proposal explicitly requests a change and the appropriate owner approves it.

### Treatment Planning

Remains owner of planned treatment context and treatment lifecycle/status.

### Performed Procedure

Remains owner of the complete finalized procedure record. Clinical Closure must not become a duplicate procedure editor.

### Clinical Record History

Remains a historical presentation boundary. No persistence mechanism is inferred.

### Clinical Workspace

Remains owner of general clinical documentation. Clinical Closure Summary remains closure-specific.

No dependency may be changed by assumption.

## 9. Runtime / persistence impact

**UNDETERMINABLE — concrete change required**

The v1.3 freeze explicitly does not authorize:

- backend/API implementation;
- database schema changes;
- automatic Shared Visit mutation;
- automatic Treatment Planning mutation;
- automatic Performed Procedure creation;
- automatic Clinical Record History creation;
- scheduling/queue behavior;
- `Close Visit` behavior.

A v1.4 proposal may request one of these only as an explicit, separately auditable change. It must not be inferred from a UI request.

## 10. Figma impact

**NO WRITE AUTHORIZED**

The frozen canonical frame remains protected.

No Figma implementation should begin until:

1. the v1.4 problem is defined;
2. the proposed behavior is defined;
3. the impact/dependency audit is rerun with concrete scope;
4. architecture/field specification deltas are approved as applicable;
5. explicit implementation authorization is granted.

## 11. Backward compatibility

**PENDING**

The proposal must state whether v1.3 behavior remains valid and whether the v1.4 change is additive, modifying, or replacing.

## 12. Risk assessment

**PENDING**

A meaningful risk assessment requires a concrete proposed change.

## 13. Required scope definition before re-audit

The proposal author must define at minimum:

1. Problem — what is wrong or insufficient in v1.3?
2. Proposed Change — what capability is being requested?
3. Proposed Behavior — what should the user/system do differently?
4. User / Clinical Benefit — why is the change worth introducing?
5. Affected Areas — which module/artifacts are expected to change?
6. Ownership Impact — whether any ownership boundary changes.
7. Backward Compatibility — how v1.3 behavior is preserved or intentionally changed.
8. Acceptance Criteria — what must be true for v1.4 to be accepted.

## 14. Audit decision

**DO NOT ADVANCE TO v1.4 ARCHITECTURE OR FIELD SPECIFICATION YET.**

The correct next step is to define the actual v1.4 problem/change request, then rerun this audit against the concrete proposal.

Possible eventual outcomes remain:

- reject the change and retain v1.3;
- revise the proposal;
- approve the proposal for v1.4 specification work.

## 15. Final verdict

**Clinical Closure v1.4 Change Impact & Dependency Audit: BLOCKED — UNDEFINED CHANGE SCOPE**

This result is intentional and protective. It prevents unnecessary design work and prevents a new version from being created without a real problem to solve.

**v1.3 remains frozen and authoritative.**

Date: 2026-08-12
